Focused Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Hold |
0
| – | – | – | 713 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 721 |
|
2016
Q4 | – | Sell |
-40
| Closed | -$5K | – | 744 |
|
2016
Q3 | $5K | Sell |
40
-50
| -56% | -$6.25K | ﹤0.01% | 539 |
|
2016
Q2 | $11K | Hold |
90
| – | – | 0.01% | 432 |
|
2016
Q1 | $13K | Hold |
90
| – | – | 0.01% | 366 |
|
2015
Q4 | $17K | Hold |
90
| – | – | 0.01% | 336 |
|
2015
Q3 | $14K | Hold |
90
| – | – | 0.01% | 347 |
|
2015
Q2 | $16K | Hold |
90
| – | – | 0.01% | 342 |
|
2015
Q1 | $16K | Hold |
90
| – | – | 0.01% | 354 |
|
2014
Q4 | $17K | Hold |
90
| – | – | 0.01% | 334 |
|
2014
Q3 | $15K | Sell |
90
-40
| -31% | -$6.67K | 0.01% | 367 |
|
2014
Q2 | $20K | Hold |
130
| – | – | 0.02% | 311 |
|
2014
Q1 | $20K | Sell |
130
-130
| -50% | -$20K | 0.02% | 286 |
|
2013
Q4 | $35K | Buy |
260
+120
| +86% | +$16.2K | 0.03% | 205 |
|
2013
Q3 | $16K | Buy |
+140
| New | +$16K | 0.02% | 308 |
|